Eli Lilly: According to US Securities and Exchange Commission documents, asset impairment, restructuring, and other special expenses confirmed in the three months ending September 30 was US$303 million.

Zhitongcaijing · 3d ago
Eli Lilly: According to US Securities and Exchange Commission documents, asset impairment, restructuring, and other special expenses confirmed in the three months ending September 30 was US$303 million.